Scarica l'app Stockscreener
5.00
3.09%
0.15
Dopo l'orario di chiusura:
4.88
-0.12
-2.40%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SLDB Giù?
Forum
Previsione
Frazionamento azionario
Solid Biosciences Inc Borsa (SLDB) Ultime notizie
(SLDB) Investment Analysis - Stock Traders Daily
Is Solid Biosciences (NASDAQ:SLDB) In A Good Position To Invest In Growth? - Simply Wall St
Perceptive Advisors LLC's Strategic Acquisition in Solid Bioscie - GuruFocus.com
Vestal Point Capital, LP Increases Stake in Solid Biosciences Inc. - GuruFocus.com
FY2024 Earnings Estimate for SLDB Issued By Chardan Capital - MarketBeat
Solid Biosciences to Present at the Jefferies London Healthcare Conference - GlobeNewswire
Solid Biosciences CEO to Present at Jefferies London Healthcare Conference | SLDB Stock News - StockTitan
Solid Biosciences' SWOT analysis: DMD therapy stock faces pivotal moment - Investing.com India
Solid Biosciences' SWOT analysis: DMD therapy stock faces pivotal moment By Investing.com - Investing.com UK
JPMorgan Chase & Co. Lowers Solid Biosciences (NASDAQ:SLDB) Price Target to $12.00 - MarketBeat
HC Wainwright Analysts Decrease Earnings Estimates for SLDB - MarketBeat
Research Analysts Issue Forecasts for SLDB FY2024 Earnings - MarketBeat
We're Keeping An Eye On Solid Biosciences' (NASDAQ:SLDB) Cash Burn Rate - Yahoo Finance
Solid Biosciences Inc. (NASDAQ:SLDB) Receives $15.67 Consensus Target Price from Brokerages - MarketBeat
Solid Biosciences (NASDAQ:SLDB) Given Buy Rating at HC Wainwright - MarketBeat
Solid Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Updates - The Manila Times
Solid Biosciences: SGT-003 Trial Shows Promise, $171M Cash Runway Despite Wider Q3 Loss | SLDB Stock News - StockTitan
Senhwa Biosciences announces first patient dosed in the Phase I/II study of Silmitasertib in children and young adults with relapsed refractory solid tumors. - PR Newswire
Where are the Opportunities in (SLDB) - Stock Traders Daily
Exosome Therapies on the Rise as 70+ Major Companies Driving Development in the Field | DelveInsight - The Malaysian Reserve
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Millennium Management LLC Reduces Stake in Solid Biosciences Inc - GuruFocus.com
Sow Good to Hold Third Quarter 2024 Conference Call on Thursday, November 14, 2024 at 10:00 a.m. ET - The Manila Times
Solid Biosciences to Participate at the Truist Securities BioPharma Symposium - GlobeNewswire
Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace
Global Exosome Market to Surge at a Tremendous CAGR of ~20% by 2030 | DelveInsight - GlobeNewswire
Duchenne Muscular Dystrophy Therapeutics Market Trends, Growth Insights, and Forecasts 2033 - WhaTech
WRN inhibitor IDE-275 gains IND clearance for phase I study in MSI-high tumors - BioWorld Online
IDEAYA Biosciences Announces IND-Clearance for Werner Helicase Development Candidate IDE275 (GSK959) for a Phase 1 Study in MSI-High Solid Tumors - BioSpace
(SLDB) Proactive Strategies - Stock Traders Daily
Pillar Biosciences Receives CPT® Code for FDA Approved oncoReveal™ CDx Pan-Cancer Solid tumor IVD Kit - PR Newswire
Solid Biosciences CMO sells $18,999 in stock - Investing.com India
Solid Biosciences CMO sells $18,999 in stock By Investing.com - Investing.com Canada
Insider Selling: Solid Biosciences Inc. (NASDAQ:SLDB) Insider Sells 2,923 Shares of Stock - MarketBeat
Kintara Therapeutics Announces 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences - Quantisnow
Seraxis gains IND clearance for islet replacement therapy - BioWorld Online
(SLDB) Trading Signals - Stock Traders Daily
Solid Biosciences Inc (SLDB) did well last session? - US Post News
Keeping an Eye on Solid Biosciences Inc (SLDB) After Insider Trading Activity - Knox Daily
Cubist Systematic Strategies LLC Sells 74,908 Shares of Huron Consulting Group Inc. (NASDAQ:HURN) - Defense World
Cubist Systematic Strategies LLC Has $368,000 Stock Position in Metropolitan Bank Holding Corp. (NYSE:MCB) - Defense World
Cubist Systematic Strategies LLC Makes New $378,000 Investment in Cryoport, Inc. (NASDAQ:CYRX) - Defense World
Great Lakes Dredge & Dock Co. (NASDAQ:GLDD) Shares Sold by Cubist Systematic Strategies LLC - Defense World
Cubist Systematic Strategies LLC Makes New $362,000 Investment in Anterix Inc. (NASDAQ:ATEX) - Defense World
Aegon Ltd. (NYSE:AEG) Stake Raised by Cubist Systematic Strategies LLC - Defense World
SG Americas Securities LLC Lowers Stock Position in Pool Co. (NASDAQ:POOL) - Defense World
Lindsay Co. (NYSE:LNN) Shares Sold by Cubist Systematic Strategies LLC - Defense World
Cubist Systematic Strategies LLC Sells 23,029 Shares of The St. Joe Company (NYSE:JOE) - Defense World
Solid Biosciences Inc. (NASDAQ:SLDB) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Ono and Ligachem sign licensing agreement for ADC LCB-97 for solid tumors - BioWorld Online
SLDB (Solid Biosciences Inc) may reap gains as insiders became active recently - Knox Daily
Nona Biosciences Enters Strategic Collaboration with OverT Bio to Advance Next-Generation Cell Therapies for Solid Tumors - BioSpace
A Deep Dive into Solid Biosciences Inc (SLDB) Stock Performance - The InvestChronicle
Solid Biosciences Inc. (NASDAQ:SLDB) Shares Acquired by Millennium Management LLC - MarketBeat
MBX Biosciences outlook solid with JPMorgan's overweight rating, eyes key catalysts in next 12 months - Investing.com
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):